Uninsured Patients Experience Delays in Obtaining Arteriovenous Access for Hemodialysis Uninsured Patients Experience Delays in Obtaining Arteriovenous Access for Hemodialysis
Uninsured patients who start in-center hemodialysis with a central venous catheter are less likely than those already on Medicare or Medicaid to obtain arteriovenous fistulas (AVF) or grafts (AVG) by their fourth month of dialysis, when they become Medicare eligible, according to a new study.Reuters Health Information (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - November 5, 2018 Category: Consumer Health News Tags: Medscape Today News Source Type: news

Anticoagulation for people with cancer and central venous catheters
This review found moderate-certainty evidence that LMWH reduces catheter ‐related venous thromboembolism (CR-VTE); evidence was inconclusive for LMWH effects on mortality and effects of vitamin K antagonists (VKA) on mortality or CR-VTE, and for LMWH versus VKA. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - September 28, 2018 Category: Consumer Health News Source Type: news

Routine X-Ray Not Needed After US-Guided Central Line Insertion
TUESDAY, Aug. 7, 2018 -- Pneumothorax and catheter misplacement after ultrasound-guided central venous catheter (CVC) insertion are rare and thus do not justify post-procedural chest X-ray (CXR), according to a study published in the July issue of... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 7, 2018 Category: Pharmaceuticals Source Type: news

A Silver Bullet in Reducing Infections?
Silver is precious not only for its beauty and monetary value, but it may also have significant benefits in fighting off bacterial infections. Although silver is not new in the medical world—Hippocrates described its use in wound care as far back as 400 BC—the reason silver is so effective in infection control has only recently been identified. Turns out it is not the silver itself that is antimicrobial, Raul Brizuela, president and CEO of Argentum Medical, told MD+DI. Rather, it is the silver ions that are released when it is exposed to moisture. What makes these ions so effective in fighting infection is that...
Source: MDDI - July 2, 2018 Category: Medical Devices Authors: Susan Shepard Tags: Materials & D Source Type: news

Central Venous Catheter-Related Bloodstream Infection Caused by Brevibacterium casei in a Hematology Patient
We report a case of B. casei catheter-related bacteremia in a severely immunocompromised hematology patient. Our experience and data from other reported cases indicate that hematology patients with indwelling catheters are at increased risk for infection with unusual bacterial pathogens. These unusual pathogens should be identified accurately, especially in immunocompromised patients. (Source: Clinical Microbiology Newsletter)
Source: Clinical Microbiology Newsletter - June 29, 2018 Category: Microbiology Authors: Giorgio Piccinelli, Enrico Morello, Valeria Cancelli, Alessandro Turra, Michele Malagola, Giuseppe Ravizzola, Francesca Caccuri, Domenico Russo, Arnaldo Caruso, Maria Antonia De Francesco Tags: Case Report Source Type: news

Rigorous study finds widely used treatment for infection fails young cancer patients
(St. Jude Children's Research Hospital) St. Jude Children's Research Hospital found ethanol-lock therapy failed to prevent new or recurring infections in cancer patients with central venous catheters and was associated with increased complications. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - June 5, 2018 Category: International Medicine & Public Health Source Type: news

Antibiotics at the time of removal of central venous catheter to reduce morbidity and mortality in newborn infants
This Cochrane Review identified only 1 RCT which was underpowered to address the question. It compared 2 doses of cephazolin at time of removal of catheter vs. no antibiotics, and found no infant on antibiotic developed late-onset sepsis vs. 5 in the control group. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - June 1, 2018 Category: Consumer Health News Source Type: news

Pursuit Vascular wins expanded indication for antimicrobial device
ClearGuard HD antimicrobial caps [Image courtesy of Pursuit Vascular]Pursuit Vascular (Maple Grove, Minn.) today announced that it has won FDA clearance for a broader indication of its ClearGuard HD antimicrobial caps. The new indication for the caps — used as an antimicrobial device for catheter-based dialysis patients — includes reduction in the incidence of central-line associated bloodstream infection in hemodialysis patients with central venous catheters. Get the full story on our sister site Medical Design & Outsourcing.  The post Pursuit Vascular wins expanded indication for antimicrobial d...
Source: Mass Device - May 30, 2018 Category: Medical Devices Authors: Chris Newmarker Tags: 510(k) Business/Financial News Catheters Dialysis Food & Drug Administration (FDA) News Well Regulatory/Compliance infections Pursuit Vascular Source Type: news

Cathflo Activase (Alteplase Powder for Reconstitution for Use in Central Venous Access Devices) - updated on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - March 19, 2018 Category: Drugs & Pharmacology Source Type: news

Boston Children ’ s, Boston Pediatric Device Consortium announces device challenge winners
The Boston Pediatric Device Strategic Partner Challenge recently announced its winners, including cardiovascular devices that expand to keep pace with growing child, a nitric oxide generator, a cardiovascular diagnostic device and other novel pediatric devices. The challenge, run by the Innovation and Digital Health Accelerator at Boston Children’s Hospital and the Boston Pediatric Device Consortium, announced a total of five winners for the challenge. Winners will receive a combination of up to $50,000 in funding per grant award and possible mentorship programs with medical device strategic partners, including Bosto...
Source: Mass Device - January 25, 2018 Category: Medical Devices Authors: Fink Densford Tags: Business/Financial News Research & Development Boston Children's Hospital Boston Scientific CryoLife Edwards Lifesciences johnsonandjohnson Medtronic Ximedica LLC Source Type: news

Bluegrass Vascular launches pivotal study for Surfacer vascular access catheter
Bluegrass Vascular Technologies said it enrolled the first patients in a pivotal trial of its Surfacer “inside-out” vascular access catheter. The Surfacer device is designed to provide access to the jugular vein to restore central venous access in hemodialysis patients with blocked neck veins; it won CE Mark approval in the European Union in August 2016; Bluegrass later inked an EU distribution deal with Merit Medical (NSDQ:MMSI) that included an equity stake. Surfacer is designed to be threaded through the femoral vein up to and into blockages in the jugular, which acts as a stabi...
Source: Mass Device - January 18, 2018 Category: Medical Devices Authors: Brad Perriello Tags: Clinical Trials Vascular Bluegrass Vascular Technologies Source Type: news

US improves success rate of pediatric artery cannulation
Ultrasound-guided radial artery cannulation in children is twice as successful...Read more on AuntMinnie.comRelated Reading: $10 microchip transforms ultrasound from 2D to 3D Point-of-care ultrasound helps find fluid Use of ultrasound to guide central venous catheters lags ASE, SCA issue vascular cannulation US guideline US guidance keeps central catheter placement on target (Source: AuntMinnie.com Headlines)
Source: AuntMinnie.com Headlines - December 20, 2017 Category: Radiology Source Type: news

Could CDC ’s New Catheter-Site Dressing Advice Curb Infections?
To help prevent intravascular catheter-related infections, the Centers for Disease Control (CDC) has updated its guidelines on catheter-site dressing regimens. The CDC now advises that for patients aged 18 years and older, “Chlorhexidine-impregnated dressings with an FDA-cleared label that specifies a clinical indication for reducing catheter-related bloodstream infection (CRBSI) or catheter-associated bloodstream infection (CABSI) are recommended to protect the insertion site of short-term, non-tunneled central venous catheters (1A)." Previously, according to its 2011 guidelines, the CDC recommended the use of ...
Source: MDDI - November 15, 2017 Category: Medical Devices Authors: Daphne Allen Tags: Medical Device Business Source Type: news

Initiatives to Reduce Catheter-Related Complications Drive U.S. Vascular Access Devices and Accessories Market
Conclusion The U.S. market for vascular access devices will continue to grow through 2024, and will be spurred by new catheter technology and accessories intended to improve patient outcomes. Going forward, healthcare workers will follow appropriate usage guidelines in greater numbers, and purchasers will exercise preference towards catheters and other products that reduce complications. The specialized catheter securement market is poised to benefit considerably from these trends. References U.S. Vascular Access Device Market – 2018. iData Research. Chopra V, Flanders S, Saint S, Woller S, O'Grady N, Safdar N et al...
Source: MDDI - November 7, 2017 Category: Medical Devices Tags: Tubing Medical Device Business Source Type: news

Fighting for the next family: Mom ’s experience inspires nutrition support guidelines
As Michelle Marti watched her twin sons, Nicholas and Max, run around the playground, she worried. To a stranger — like the representative of their local school’s Planning and Placement Team (PPT), there to evaluate the boys’ eligibility for special needs services in kindergarten — they looked like any other kids having fun. But their playfulness masked a serious illness: short bowel syndrome, the result of a condition called Hirschsprung’s disease. “They look healthy on the outside because all of their medical differences are under their clothes,” admits Michelle. Those difference...
Source: Thrive, Children's Hospital Boston - October 24, 2017 Category: Pediatrics Authors: Jessica Cerretani Tags: Diseases & Conditions Our Patients’ Stories Parenting Center for Advanced Intestinal Rehabilitation Hirschsprung's disease Jessica McCaig short bowel syndrome (SBS). total parenteral nutrition Source Type: news

Ultrasound-Guided Central Venous Catheter Placement Ultrasound-Guided Central Venous Catheter Placement
What are the latest recommendations for the use of ultrasound during central venous catheter placement?Critical Care (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - September 29, 2017 Category: Consumer Health News Tags: Critical Care Journal Article Source Type: news

Biopatch for venous or arterial catheter sites
This medtech innovation briefing covers Biopatch, a hydrophilic foam dressing impregnated with chlorhexidine gluconate (CHG), and is used for covering central venous or arterial catheter sites. It releases CHG to reduce the risk of catheter-related bloodstream infections (CRBSIs), while the absorbent foam draws discharge away from the catheter site. The intendedplace in therapy would be as an addition to standard sterile semipermeable transparent dressings to reduce the risk of a CRBSI in people with venous or arterial catheters. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 18, 2017 Category: Consumer Health News Source Type: news

7 medtech stories we missed this week: August 4, 2017
[Image from unsplash.com]From MDCorp inking a European distribution deal to Align Technology’s North Carolina expansion, here are seven medtech stories we missed this week but thought were still worth mentioning. 1. MDCorp inks distribution deal with Smart Endoscope Systems MDCorp announced in a July 31 press release that it has signed a distribution agreement with Smart Endoscope Systems, giving MDCorp permission to sell Smart’s G-Eye system throughout its European market. Neuraxon, which is in the process of merging with MDCorp, is going to be responsible for distributing the G-Eye system in Europe and a netw...
Source: Mass Device - August 4, 2017 Category: Medical Devices Authors: Danielle Kirsh Tags: Food & Drug Administration (FDA) Imaging Ultrasound Vascular Weight loss Access Scientific Inc. aligntechnology Central California Blood Center Cerus Corp. FujiFilm Medical Systems MDCorp MedTech Smart Endoscope Systems Standard Source Type: news

Cathflo Activase (Alteplase Powder for Reconstitution for Use in Central Venous Access Devices) - new on RxList
(Source: RxList - New and Updated Drug Monographs)
Source: RxList - New and Updated Drug Monographs - July 12, 2017 Category: Drugs & Pharmacology Source Type: news

Bio2 touts pivotal data on Angel catheter-filter combo
This study of a combined IVC filter/central venous catheter was the culmination of a panel of dedicated investigators with careful guidance by the FDA,” primary investigator Dr. Victor Tapson said in prepared remarks. “The efficacy and safety of the device, simple bedside placement, and the need to remove it before discharge make it very appealing. Nearly the entire cohort had crucial, yet short-term filter needs so that discharge without a filter was preferred.” The device is the 1st to be cleared by the FDA for PE prophylaxis in critically ill patients contraindicated to anticoagulation. “The publ...
Source: Mass Device - June 30, 2017 Category: Medical Devices Authors: Sarah Faulkner Tags: Catheters Clinical Trials Vascular BiO2 Medical Source Type: news

Baxter touts HDx Theranova data for ‘ extended ’ hemodialysis
Baxter (NYSE:BAX) today released data from 2 independent studies of its novel HDx therapy using the Theranova dialyzer, touting the effective removal of small and mid-sized toxins at similar rates compared to hemodiafiltration. Results from the trial were presented at the 54th Congress of the European Renal Association and European Dialysis and Transplant Association this week, the company said. The Deerfield, Ill.-based company’s HDx therapy uses a Theranova dialyzer designed to extend the range of molecules that it filters from the blood, claiming it “more closely mimics the natural kidney,” accord...
Source: Mass Device - June 5, 2017 Category: Medical Devices Authors: Fink Densford Tags: Blood Management Clinical Trials Baxter Source Type: news

Bio2 Medical raises $1.5m, looking for $6.5m more
Bio2 Medical raised $1.5 million in a new round of debt and option financing, according to an SEC filing posted this week. Money in the round came from 1 unnamed investor, with the date of the sale noted as March 18, according to the filing. The company has not yet stated how it plans to spend funds raised during the offering. Bio2 is looking to raise an additional $6.5 million before closing the round. A portion of the proceeds from the round will be used to pay the salaries of certain company officers, according to the filing. Last August, Bio2 Medical pulled in $3 million from a 2nd tranche of financing from O...
Source: Mass Device - March 31, 2017 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Catheters BiO2 Medical Source Type: news

MassDevice.com +5 | The top 5 medtech stories for March 6, 2017
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Via Surgical inks distro deal with Progressive Medical for FasTouch Via Surgical said today it inked an exclusive US distribution deal with Progressive Medical to distribute Via’s FasTouch soft tissue suture device. Amiri...
Source: Mass Device - March 6, 2017 Category: Medical Equipment Authors: MassDevice Tags: Blog News Well Plus 5 Source Type: news

Merit Medical backs Bluegrass Vascular ’ s Surfacer ‘ inside-out ’ catheter
Bluegrass Vascular Technologies said today that it entered a “strategic relationship” with Merit Medical (NSDQ:MMSI) for its Surfacer “inside-out” catheter that includes an equity stake and a distribution agreement. The Surfacer device is designed to provide access to the jugular vein to restore central venous access in hemodialysis patients with blocked neck veins; it won CE Mark approval in the European Union last August. The catheter is threaded through the femoral vein up to and into blockage in the jugular, which acts as a stabilizer. The head of the catheter is then al...
Source: Mass Device - March 6, 2017 Category: Medical Equipment Authors: Brad Perriello Tags: Distribution Funding Roundup Vascular Wall Street Beat Bluegrass Vascular Technologies Merit Medical Systems Inc. Source Type: news

Catheter impregnation, coating or bonding for reducing central venous catheter-related infections in adults
This Cochrane Review informed a practice changing update on Dynamed Plus. It found that antimicrobial coatings that appear to reduce risk of central venous catheter-related bloodstream infection include minocycline-rifampicin, chlorhexidine silver sulfadiazine, silver, and heparin, but antimicrobial coatings do not appear to reduce risk of sepsis or mortality (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - December 2, 2016 Category: Consumer Health News Source Type: news

Staphylococcus saprophyticus Bacteremia in a Pediatric Patient with Central Venous Catheter-Associated Infection
We report a case of S. saprophyticus central venous catheter (CVC)-associated bacteremia identified by matrix-assisted laser desorption ionization-time-of-flight (MALDI-TOF) mass spectrometry and provide a review of how to report and interpret antimicrobial susceptibility results for coagulase-negative staphylococci (CoNS) when species identification is warranted. (Source: Clinical Microbiology Newsletter)
Source: Clinical Microbiology Newsletter - September 21, 2016 Category: Microbiology Authors: Peera Hemarajata, Kristina Adachi, Lynn Ramirez-Avila, Romney M. Humphries Source Type: news

FDA nod for Angel catheter triggers $3m tranche for Bio2 Medical
The 510(k) clearance Bio2 Medical won from the FDA in July for its Angel catheter triggered a 2nd, $3 million tranche from Oxford Finance last week, the company said yesterday. The Angel catheter is designed to provide access to the central venous system and to trap blood clots before they can reach the lungs, according to the Golden, Colo.-based company. The FDA cleared the device July 28, Bio2 said August 24. Bio2 said it plans to use the funds to commercialize the Angel device in the U.S. by hiring sales reps, building up inventory and working on market development. The tranche is part of an $8 million secured...
Source: Mass Device - August 31, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Catheters Funding Roundup Wall Street Beat BiO2 Medical Source Type: news

MassDevice.com +5 | The top 5 medtech stories for August 30, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Vention Medical boosts footprint in Ireland Vention Medical said today that it boosted its footprint on the Emerald Isle with the opening of a new facility on the National University of Ireland’s Galway campus. Read ...
Source: Mass Device - August 30, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Bluegrass Vascular wins CE Mark for Surfacer vascular access device
Bluegrass Vascular Technologies said today that it won CE Mark approval in the European Union for its Surfacer vascular access device and plans a limited commercial launch in 7 countries there. Surfacer is designed to restore central venous access in patients with occluded veins. San Antonio-based Bluegrass Vascular, which drummed up a $4.5 million Series A round 2 years ago to back its CE Mark bid, said it plans to put Surfacer on the market in the U.K., Germany, Austria, Italy, Holland, Belgium and Luxembourg. The company said it’s also set to begin a post-market registry study of the device. &l...
Source: Mass Device - August 30, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Regulatory/Compliance Vascular Bluegrass Vascular Technologies Source Type: news

Skin antisepsis for reducing central venous catheter-related infections
This review concludes that it is not clear whether cleaning skin around CVC insertion sites with antiseptic reduces catheter related blood stream infection vs. no skin cleansing. Very low quality evidence suggests chlorhexidine may reduce rates of infection and catheter colonisation vs. povidone iodine. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - August 24, 2016 Category: Consumer Health News Source Type: news

NIH announces winners of undergraduate biomedical engineering design competition
(NIH/National Institute of Biomedical Imaging& Bioengineering) In a nation-wide competition, six teams of undergraduate engineering students produced prize-winning designs for technological advances to improve human health. The Design by Biomedical Undergraduate Teams (DEBUT) Challenge winning teams designed tools for a myriad of health care challenges, including diagnosing tuberculosis (TB) in children and a safer alternative for central venous catheter placements. (Source: EurekAlert! - Cancer)
Source: EurekAlert! - Cancer - August 23, 2016 Category: Cancer & Oncology Source Type: news

Lungpacer Medical hits the FDA fast track with phrenic nerve pacer
Lungpacer Medical said it won an expedited access pathway designation from the FDA for the diaphragm pacing system it’s developing to treat patients who can’t be weaned from mechanical ventilation. The Lungpacer DPS device is a neurostimulation system designed to exercise and strengthen the diaphragm via the temporary, transcatheter stimulation of the phrenic nerve. The FDA’s EAP designation is for breakthrough therapies aimed at unmet clinical needs and seeks lower the cost and amount of time it takes to get the treatment to market. “Our team is thrilled that the Lungpacer DPS was granted EAP ...
Source: Mass Device - May 11, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Food & Drug Administration (FDA) Neuromodulation/Neurostimulation Regulatory/Compliance Respiratory Expedited Access Program (EAP) Lungpacer Medical Source Type: news

MassDevice.com +5 | The top 5 medtech stories for April 29, 2016
Say hello to MassDevice +5, a bite-sized view of the top five medtech stories of the day. This feature of MassDevice.com’s coverage highlights our 5 biggest and most influential stories from the day’s news to make sure you’re up to date on the headlines that continue to shape the medical device industry. Get this in your inbox everyday by subscribing to our newsletters.   5. Hill-Rom slides on Q2 revenues miss Hill-Rom shares took a hit today after the company reported that fiscal 2nd-quarter sales missed expectations despite the contribution of new acquisition Welch Allyn. Chicago-based Hill-Rom s...
Source: Mass Device - April 29, 2016 Category: Medical Equipment Authors: MassDevice Tags: News Well Plus 5 Source Type: news

Merit Medical looks to capitalize on rival Cook’s recall
Merit Medical (NSDQ:MMSI) chief Fred Lampropoulos said his company is ready to take advantage of the worldwide recall of rival Cook Medical‘s central catheter sets. The FDA in March slapped the Cook recall with a Class I label, denoting the risk of serious injury or death. It covers Cook’s single lumen central venous catheter sets and trays, single lumen pressure monitoring sets and trays, femoral artery pressure monitoring catheter sets and trays and radial artery pressure monitoring catheter sets and trays. During a conference call with analysts yesterday discussing Merit’s 1st-quart...
Source: Mass Device - April 29, 2016 Category: Medical Equipment Authors: Brad Perriello Tags: Catheters Food & Drug Administration (FDA) MassDevice Earnings Roundup Recalls Regulatory/Compliance Cook Medical Merit Medical Systems Inc. Source Type: news

FDA releases February 2016 510(k) clearances
February 2016 510(k) Clearances 510(k) summaries or 510(k) statements for final decisions rendered during the period February 2016. TOTAL 510(k)s THIS PERIOD 224 TOTAL WITH SUMMARIES 213 TOTAL WITH STATEMENTS 11 February 2016 510(k) Clearances 510(K) SUMMARIES OR 510(K) STATEMENTS FOR FINAL DECISIONS RENDERED DURING THE PERIOD February 2016 DEVICE: ANI Monitor MDOLORIS MEDICAL SYSTEMS SAS 510(k) NO: K142969(Traditional) ATTN: MATHILDE COLLET PHONE NO : 011 333 62092081 6, RUE DU PR LAGUESSE SE DECISION MADE: 23-FEB-16 LILLE FR 59037 510(k) SUMMARY AVAILABLE FROM FDA DEVICE: DBSWIN and VistaEasy Imaging Software Durr Dental...
Source: Mass Device - April 5, 2016 Category: Medical Equipment Authors: MassDevice Tags: 510(k) Food & Drug Administration (FDA) Regulatory/Compliance Source Type: news

FDA: Cook Medical central venous cath recall is Class I
The FDA today labeled Cook Medical‘s recall of its central venous catheter and pressure monitoring sets and trays as Class I over issues with tip splitting and separation. The devices being recalled are used to monitor pressure in a patient’s vein or artery, to sample blood and to administer drugs or fluids. Class I recall designations, the FDA’s most serious classification of recall, are used when there is a reasonable probability that product use could cause serious adverse health consequences or death. The devices are being recalled over issues with device tips splitting or separating from the catheter...
Source: Mass Device - March 30, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Catheters Food & Drug Administration (FDA) Recalls Cook Medical Source Type: news

Class I Medical Device Recall: Cook Medical Recalls Central Venous Catheter and Pressure Monitoring Sets and Trays due to Tips that May Split or Separate
Cook Medical is recalling these devices because the tips may split or separate from the catheters due to a manufacturing error. If this occurs, the tip could enter the patient’s bloodstream. (Source: Food and Drug Adminstration (FDA): CDRHNew)
Source: Food and Drug Adminstration (FDA): CDRHNew - March 30, 2016 Category: Medical Equipment Source Type: news

Antibiotic-Impregnated Catheters and Risk for Infections in KidsAntibiotic-Impregnated Catheters and Risk for Infections in Kids
Antibiotic-impregnated central venous catheters may reduce the risk of pediatric bloodstream infections better than heparin-impregnated or standard central venous catheters, according to research from the United Kingdom. Reuters Health Information (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - March 23, 2016 Category: Intensive Care Tags: Pediatrics News Source Type: news

Frequency of dressing changes for central venous access devices on catheter-related infections
The review set out to assess the effect of the frequency of CVAD dressing changes on the incidence of CRIs and other outcomes including pain and skin damage. The review concludes that in the absence of clear evidence of an increased risk associated with extending the time between dressing changes, it is reasonable to base decisions on patient preference and cost. CVAD sites should be inspected on a daily basis to ensure dressings are clean and intact with no signs of localised infection. Clinically indicated dressing changes should occur if the dressing is soiled or not intact. (Source: Current Awareness Service for Health (CASH))
Source: Current Awareness Service for Health (CASH) - March 1, 2016 Category: Consumer Health News Source Type: news

Versago raises $1.7m for ‘reverse needle’ access port
Versago Vascular Access said today it received $1.7 million in seed funding from Primo Medical Group’s network of investors to support its “reverse needle” subcutaneous access port. West Bridgewater, Mass.-based Versago, a spinoff of Primo Medical Group, has designed and developed a subcutaneous port to access the body’s bloodstream and anatomical cavities that collect serous or ascitic fluid, according to the company. “No one could have ever imagined that subcutaneous port access could be simplified by having the needle advance out of the port body instead of into the body of the port. This w...
Source: Mass Device - February 26, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Business/Financial News Implants Vascular Primo Medical Group Versago Vascular Access Source Type: news

Cook Medical recalls select single lumen caths
Cook Medical is recalling 360 lots of its single lumen central venous catheters, pressure monitoring sets and trays due to issues with catheter tip fracture and separation. A total of 17,872 devices are subject to the recall, according to Cook, who said it began notifying customers and distributors of the issue in January and that it has contacted the FDA and other regulatory bodies over the issue. The problem was discovered during an internal inspection, in which a catheter “exhibited the potential for catheter tip fracture and/or separation,” according to an FDA press release. Cook Medical said they investiga...
Source: Mass Device - February 11, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Catheters Food & Drug Administration (FDA) Recalls Vascular Cook Medical Source Type: news

Cook Medical Issues Global Recall of Select Lots of Central Venous Catheters and Pressure Monitoring Sets and Trays
On January 6, 2016, Cook Medical initiated a voluntary recall of 360 specific lots of Single Lumen Central Venous Catheters and Pressure Monitoring Sets and Trays due to catheter tip fracture and/or separation. Globally, 17,827 devices are subject to this recall. (Source: Food and Drug Administration)
Source: Food and Drug Administration - February 11, 2016 Category: Food Science Source Type: news

BiO2 Medical drums up $8m from Oxford Finance
Oxford Finance said yesterday it closed an $8 million secured term loan with Angel catheter maker BiO2 Medical, with funds slated to support FDA clearance and an anticipated commercial launch of the catheter in mid-2016. The Angel catheter is designed to provide access to the central venous system and to trap blood clots before they can reach the lungs, according to the San Antonio, Texas-based company. “With this equity and venture debt capital secured, we are on the path to commercializing the Angel Catheter in the U.S. We anticipate providing pulmonary embolism prophylaxis to over one million patients who are...
Source: Mass Device - January 29, 2016 Category: Medical Equipment Authors: Fink Densford Tags: Blood Management Business/Financial News Catheters BiO2 Medical Source Type: news

Central Venous Catheter Intravascular MalpositioningCentral Venous Catheter Intravascular Malpositioning
Find out the best ways to prevent, identify, and correct the unintended placement of CVCs. Western Journal of Emergency Medicine: Integrating Emergency Care with Population Health (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - January 22, 2016 Category: Consumer Health News Tags: Emergency Medicine Journal Article Source Type: news

Best Central Venous Catheter Location?Best Central Venous Catheter Location?
Which vein is associated with the fewest central venous catheter complications? Medscape Critical Care (Source: Medscape General Surgery Headlines)
Source: Medscape General Surgery Headlines - January 7, 2016 Category: Surgery Tags: Critical Care Viewpoint Source Type: news

BiO2 Med miracle: Angel cath pivotal trial ends 1 year early
BiO2 Medical said today the pivotal clincial trial of its Angel catheter hit its target of 150 evaluable patients and has concluded a solid year earlier than anticipated. The Angel catheter is designed to provide access to the central venous system and to trap blood clots before they can reach the lungs, according to the San Antonio, Texas-based company. “We are very excited about completing this pivotal U.S. trial.  We have found that physicians are very enthusiastic about an IVC filter that can be placed at the bedside in patients at very high risk for acute DVT / PE, or those with VTE who temporarily cannot b...
Source: Mass Device - December 21, 2015 Category: Medical Equipment Authors: Fink Densford Tags: Catheters Clinical Trials BiO2 Medical Source Type: news

Fewer Complications With Subclavian CatheterizationFewer Complications With Subclavian Catheterization
Central venous catheterization of the subclavian vein showed the lowest risks for bloodstream infections and symptomatic thrombosis compared with insertions at the jugular or femoral veins. Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 25, 2015 Category: Intensive Care Tags: Critical Care News Source Type: news

Central Venous Catheter Insertion: Is the Subclavian Vein the Safest Option? (FREE)
By Amy Orciari Herman Edited by Susan Sadoughi, MD Catheterization of the subclavian vein is associated with lower risk for major catheter-related complications than insertion at the femoral or jugular vein, according to a New England Journal of Medicine study.Among adults … (Source: Physician's First Watch current issue)
Source: Physician's First Watch current issue - September 24, 2015 Category: Primary Care Source Type: news

Peripherally inserted central catheters can cause blood clots in lower limbs
Peripherally inserted central catheters (PICCs) are frequently used by healthcare professionals to obtain long-term central venous access in hospitalized patients. While there are numerous benefits associated with PICCs, a potential complication is deep vein thrombosis (DVT), or blood clots, in upper limbs. A new study of more than 70,000 patients in hospitals indicates that PICC use is associated not only with upper-extremity DVT, but also with lower-extremity DVT. (Source: ScienceDaily Headlines)
Source: ScienceDaily Headlines - August 17, 2015 Category: Science Source Type: news

Peripherally inserted central catheters can cause blood clots in lower limbs
(Elsevier Health Sciences) Peripherally inserted central catheters (PICCs) are frequently used by healthcare professionals to obtain long-term central venous access in hospitalized patients. While there are numerous benefits associated with PICCs, a potential complication is deep vein thrombosis (DVT), or blood clots, in upper limbs. A new study of more than 70,000 patients in 48 Michigan hospitals indicates that PICC use is associated not only with upper-extremity DVT, but also with lower-extremity DVT. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - August 17, 2015 Category: Global & Universal Source Type: news